View ValuationEcomembrane 将来の成長Future 基準チェック /36Ecomembraneは、14.5%と17.7%でそれぞれ年率14.5%で利益と収益が成長すると予測される一方、EPSはgrowで16.2%年率。主要情報14.5%収益成長率16.23%EPS成長率Machinery 収益成長22.7%収益成長率17.7%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日17 Apr 2026今後の成長に関する最新情報Price Target Changed • Apr 13Price target decreased by 8.5% to €6.50Down from €7.10, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €4.96. Stock is up 36% over the past year.すべての更新を表示Recent updatesBuy Or Sell Opportunity • May 05Now 20% undervaluedOver the last 90 days, the stock has risen 3.5% to €5.05. The fair value is estimated to be €6.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 18% per annum. Earnings are also forecast to grow by 15% per annum over the same time period.Upcoming Dividend • May 04Inaugural dividend of €0.096 per shareEligible shareholders must have bought the stock before 11 May 2026. Payment date: 13 May 2026. This is the first dividend for Ecomembrane since going public. The average dividend yield among industry peers is 1.0%.Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €5.65, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 14x in the Machinery industry in Italy. Total returns to shareholders of 38% over the past year.New Risk • Apr 17New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (21% accrual ratio). Minor Risk Market cap is less than US$100m (€21.5m market cap, or US$25.3m).Price Target Changed • Apr 13Price target decreased by 8.5% to €6.50Down from €7.10, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €4.96. Stock is up 36% over the past year.Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €26.3m (up 30% from FY 2024). Net income: €1.14m (up €975.5k from FY 2024). Profit margin: 4.3% (up from 0.8% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Machinery industry in Italy.お知らせ • Apr 06Ecomembrane S.p.A., Annual General Meeting, Apr 21, 2026Ecomembrane S.p.A., Annual General Meeting, Apr 21, 2026, at 17:15 W. Europe Standard Time.お知らせ • Mar 24Ecomembrane S.p.A. announces Annual dividend, payable on May 13, 2026Ecomembrane S.p.A. announced Annual dividend of EUR 0.0960 per share payable on May 13, 2026, ex-date on May 11, 2026 and record date on May 12, 2026.New Risk • Mar 19New major risk - Revenue and earnings growthEarnings have declined by 84% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 84% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€21.0m market cap, or US$24.2m).New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€18.0m market cap, or US$21.3m).お知らせ • Feb 03+ 1 more updateEcomembrane S.p.A. to Report First Half, 2026 Results on Sep 25, 2026Ecomembrane S.p.A. announced that they will report first half, 2026 results on Sep 25, 2026分析記事 • Oct 01Is Ecomembrane (BIT:ECMB) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Buy Or Sell Opportunity • Apr 15Now 27% overvaluedOver the last 90 days, the stock has fallen 15% to €3.90. The fair value is estimated to be €3.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 21% per annum. Earnings are also forecast to grow by 53% per annum over the same time period.New Risk • Apr 02New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 236% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.8% net profit margin). Market cap is less than US$100m (€16.7m market cap, or US$18.2m).お知らせ • Jan 27+ 1 more updateEcomembrane S.p.A. to Report Fiscal Year 2024 Results on Mar 14, 2025Ecomembrane S.p.A. announced that they will report fiscal year 2024 results on Mar 14, 2025お知らせ • Oct 14BayWa r.e. bioenergy GmbH completed the acquisition of 37.8932% stake in Alvus S.r.l and Favus S.r.l.- Favus Gmbhfrom from Ecomembrane S.r.l.BayWa r.e. bioenergy GmbH signed an agreement to acquire a 18.9466% stake in Alvus S.r.l and Favus S.R.L. - Favus Gmbh from Ecomembrane S.r.l. on August 9, 2023. The agreement, in addition to providing a set of declarations and guarantees, provides for the occurrence of certain conditions precedent before the closing, expected by the end 2023. BayWa r.e. bioenergy GmbH completed the acquisition of 18.9466% stake in Alvus S.r.l and Favus S.R.L. - Favus Gmbh from Ecomembrane S.r.l. on October 12, 2023.New Risk • Aug 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 4.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (4.7% average weekly change). Market cap is less than US$100m (€33.3m market cap, or US$36.2m).業績と収益の成長予測BIT:ECMB - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202848223112/31/202745212112/31/202641101112/31/2025261-1-1N/A9/30/202524101N/A6/30/202523023N/A3/31/202521012N/A12/31/202420011N/A9/30/2024190-10N/A6/30/2024170-2-1N/A3/31/2024161-20N/A12/31/2023151-30N/A12/31/202215212N/A12/31/2021121N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: ECMBの予測収益成長率 (年間14.5% ) は 貯蓄率 ( 3.3% ) を上回っています。収益対市場: ECMBの収益 ( 14.5% ) はItalian市場 ( 10.6% ) よりも速いペースで成長すると予測されています。高成長収益: ECMBの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: ECMBの収益 ( 17.7% ) Italian市場 ( 5.6% ) よりも速いペースで成長すると予測されています。高い収益成長: ECMBの収益 ( 17.7% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: ECMBの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YCapital-goods 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/08 08:24終値2026/05/08 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ecomembrane S.p.A. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Luigi De BellisEquita SIM S.p.A.Roberto LetiziaEquita SIM S.p.A.Domenico GhilottiEquita SIM S.p.A.
Price Target Changed • Apr 13Price target decreased by 8.5% to €6.50Down from €7.10, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €4.96. Stock is up 36% over the past year.
Buy Or Sell Opportunity • May 05Now 20% undervaluedOver the last 90 days, the stock has risen 3.5% to €5.05. The fair value is estimated to be €6.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 18% per annum. Earnings are also forecast to grow by 15% per annum over the same time period.
Upcoming Dividend • May 04Inaugural dividend of €0.096 per shareEligible shareholders must have bought the stock before 11 May 2026. Payment date: 13 May 2026. This is the first dividend for Ecomembrane since going public. The average dividend yield among industry peers is 1.0%.
Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €5.65, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 14x in the Machinery industry in Italy. Total returns to shareholders of 38% over the past year.
New Risk • Apr 17New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (21% accrual ratio). Minor Risk Market cap is less than US$100m (€21.5m market cap, or US$25.3m).
Price Target Changed • Apr 13Price target decreased by 8.5% to €6.50Down from €7.10, the current price target is provided by 1 analyst. New target price is 31% above last closing price of €4.96. Stock is up 36% over the past year.
Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €26.3m (up 30% from FY 2024). Net income: €1.14m (up €975.5k from FY 2024). Profit margin: 4.3% (up from 0.8% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Machinery industry in Italy.
お知らせ • Apr 06Ecomembrane S.p.A., Annual General Meeting, Apr 21, 2026Ecomembrane S.p.A., Annual General Meeting, Apr 21, 2026, at 17:15 W. Europe Standard Time.
お知らせ • Mar 24Ecomembrane S.p.A. announces Annual dividend, payable on May 13, 2026Ecomembrane S.p.A. announced Annual dividend of EUR 0.0960 per share payable on May 13, 2026, ex-date on May 11, 2026 and record date on May 12, 2026.
New Risk • Mar 19New major risk - Revenue and earnings growthEarnings have declined by 84% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 84% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€21.0m market cap, or US$24.2m).
New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Market cap is less than US$100m (€18.0m market cap, or US$21.3m).
お知らせ • Feb 03+ 1 more updateEcomembrane S.p.A. to Report First Half, 2026 Results on Sep 25, 2026Ecomembrane S.p.A. announced that they will report first half, 2026 results on Sep 25, 2026
分析記事 • Oct 01Is Ecomembrane (BIT:ECMB) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Buy Or Sell Opportunity • Apr 15Now 27% overvaluedOver the last 90 days, the stock has fallen 15% to €3.90. The fair value is estimated to be €3.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 21% per annum. Earnings are also forecast to grow by 53% per annum over the same time period.
New Risk • Apr 02New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 236% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.8% net profit margin). Market cap is less than US$100m (€16.7m market cap, or US$18.2m).
お知らせ • Jan 27+ 1 more updateEcomembrane S.p.A. to Report Fiscal Year 2024 Results on Mar 14, 2025Ecomembrane S.p.A. announced that they will report fiscal year 2024 results on Mar 14, 2025
お知らせ • Oct 14BayWa r.e. bioenergy GmbH completed the acquisition of 37.8932% stake in Alvus S.r.l and Favus S.r.l.- Favus Gmbhfrom from Ecomembrane S.r.l.BayWa r.e. bioenergy GmbH signed an agreement to acquire a 18.9466% stake in Alvus S.r.l and Favus S.R.L. - Favus Gmbh from Ecomembrane S.r.l. on August 9, 2023. The agreement, in addition to providing a set of declarations and guarantees, provides for the occurrence of certain conditions precedent before the closing, expected by the end 2023. BayWa r.e. bioenergy GmbH completed the acquisition of 18.9466% stake in Alvus S.r.l and Favus S.R.L. - Favus Gmbh from Ecomembrane S.r.l. on October 12, 2023.
New Risk • Aug 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 4.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (4.7% average weekly change). Market cap is less than US$100m (€33.3m market cap, or US$36.2m).